Cover Image

Infusion reaction to infliximab biosimilar after transitioning from infliximab

Saved in:

Bibliographic Details
Main Authors:	Reem Kashlan, MPH (Author), Alexis B. Lyons, MD (Author), Shanthi Narla, MD (Author), Iltefat H. Hamzavi, MD (Author)
Format:	Book
Published:	Elsevier, 2021-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Psoriasiform paradojic reaction associated with infliximab infusion
by: Lorena De Agustín Sierra
Published: (2017)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
by: Subedi S, et al.
Published: (2019)

Infusion Reactions to Infliximab in Pediatric Patients with Inflammatory Bowel Disease
by: Rajmohan Dharmaraj, et al.
Published: (2024)

Assessing the Extended In-Use Stability of the Infliximab Biosimilar PF-06438179/GP1111 Following Preparation for Intravenous Infusion
by: Maja Vimpolsek, et al.
Published: (2019)

Case Report: Infusion-Related Reactions to Intravenous Infliximab and Subcutaneous Ustekinumab in Pediatric Crohn's Disease
by: Toshihiko Kakiuchi, et al.
Published: (2021)

Incidence and management of infusion reactions to infliximab in 186 italian patient's with rheumatoid arthritis: the Padua experience
by: S. Todesco, et al.
Published: (2011)

Association of myalgias with compounded topical Janus kinase inhibitor use in vitiligo
by: Shanthi Narla, MD, et al.
Published: (2020)

Learnings from Regional Market Dynamics of Originator and Biosimilar Infliximab and Etanercept in Germany
by: Evelien Moorkens, et al.
Published: (2020)

Switch from Infliximab to Infliximab-dyyb for Rheumatology Indications
by: Alexi Spoto, et al.
Published: (2021)

Infliximab
by: İlgen Ertam Sağduyu
Published: (2022)

A case report of drug-induced liver injury due to the infliximab biosimilar CT-P13 on switching from original infliximab in a patient with Crohn's disease
by: Shin Kashima, et al.
Published: (2022)

Do plasticized polyvinylchloride and polyurethane infusion sets promote infliximab adsorption?
by: Chennell Philip, et al.
Published: (2020)

Pyoderma gangrenosum in pregnancy successfully treated with infliximab and prednisone
by: Julia D. Stiegler, MD, et al.
Published: (2017)

Infliximab therapy for Netherton syndrome: A case report
by: Ãngela Roda, MD, et al.
Published: (2017)

Hidradenite supurativa tratada com infliximabe Hidradenitis suppurativa treated with infliximab
by: Daniel Lago Obadia, et al.
Published: (2009)

Changes in the Penetration Rate of Biosimilar Infliximab Within Japan Using a Japanese Claims Database
by: Matsumoto T, et al.
Published: (2021)

Tratamento de hidradenite supurativa com infliximab Treatment of hidradenitis suppurativa with infliximab
by: Tiago Torres, et al.
Published: (2010)

Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system
by: An Q, et al.
Published: (2019)

Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?
by: Yujeong Kim, et al.
Published: (2020)

Under the Umbrella of Clinical Pharmacology: Inflammatory Bowel Disease, Infliximab and Adalimumab, and a Bridge to an Era of Biosimilars
by: Zvonimir Petric, et al.
Published: (2022)

Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
by: Kerry Mansell, et al.
Published: (2019)

Infliximab no tratamento da artrite psoriásica grave Infliximab in treatment of severe psoriatic arthritis
by: Adriano Jaime Consorte Loyola, et al.
Published: (2005)

Correction to: Potential cost-savings from the use of the biosimilars filgrastim, infliximab and insulin glargine in Canada: a retrospective analysis
by: Kerry Mansell, et al.
Published: (2019)

Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement
by: Paul A. Leiphart, BA, et al.
Published: (2018)

Response of Fibroblastic Rheumatism to Infliximab
by: Ricardo Romiti, et al.
Published: (2009)

Infliximab in inflammatory bowel disease
by: Konstantinos Papamichael, et al.
Published: (2019)

Treatment of severe psoriasis with infliximab
by: JA Leman, et al.
Published: (2008)

A Rare Case of Infliximab-Induced Small Vessel Vasculitis With Renal Involvement
by: Anna Way MD, et al.
Published: (2023)

Merkel cell carcinoma in a young female on infliximab
by: Alex Harrison, DO, et al.
Published: (2022)

Efficacy and safety of biosimilar infliximab CT-P13 in the treatment of psoriasis and psoriatic arthritis: 1-year follow-up
by: Patricia Shu Kurizky, et al.
Published: (2019)

Evaluation of adverse events focusing on infection associated with infliximab originator and biosimilar using a spontaneous reporting system database
by: Iku Niinomi, et al.
Published: (2019)

Early intestinal obstruction after infliximab therapy in Crohn's disease
by: Mitsuro Chiba, et al.
Published: (2019)

Cortical Vein Thrombosis after Infliximab Treatment for Crohn's Disease
by: Saeed Razmeh, et al.
Published: (2021)

Drug-induced pityriasis lichenoides from infliximab in a patient with juvenile idiopathic arthritis
by: Nicole Boswell, BS, et al.
Published: (2022)

Tuberculose esplênica durante tratamento de psoríase com infliximabe Splenic tuberculosis during psoriasis treatment with infliximab
by: Gleyce Tavares de Melo Fortaleza, et al.
Published: (2009)

Infliximab in the treatment of plaque type psoriasis
by: Rosita Saraceno, et al.
Published: (2009)

GOUT - induced by Infliximab?- case report
by: Anca Chiriac, et al.
Published: (2012)

Spitz nevus and infliximab: association or coincidence?,
by: Catarina Soares Queirós, et al.
Published: (2020)

INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
by: I.P. Nikishina, et al.
Published: (2010)

INFLIXIMAB IN TREATMENT OF REFRACTORY JUVENILE ARTHRITIS
by: I.P. Nikishina, et al.
Published: (2010)